Manzo Pharmaceuticals, Inc.
Manzo Pharmaceuticals, Inc.
Your view on MNZO
Overview
What the company does, where it operates, and who runs it.
About Manzo Pharmaceuticals, Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Kenneth Manzo
- Headquarters
- PO Box 107, Milford, PA, US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Kenneth Manzo
- Headquarters
- PO Box 107, Milford, PA, US
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies.
The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014.
Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Manzo Pharmaceuticals, Inc., and the rating behind it. MNZO last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Manzo Pharmaceuticals, Inc.. Starting points for Manzo Pharmaceuticals, Inc.: beta -44.70 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Manzo Pharmaceuticals, Inc.. Manzo Pharmaceuticals, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Manzo Pharmaceuticals, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Manzo Pharmaceuticals, Inc.. Manzo Pharmaceuticals, Inc. has reported as a listed company since 1998. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Manzo Pharmaceuticals, Inc. valued side by side against its closest peers. Manzo Pharmaceuticals, Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Manzo Pharmaceuticals, Inc., and how their positions are changing. At a $115,952 market value, institutional positions materially move Manzo Pharmaceuticals, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Manzo Pharmaceuticals, Inc. executives and directors. Shares of Manzo Pharmaceuticals, Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Manzo Pharmaceuticals, Inc.. Manzo Pharmaceuticals, Inc. is a $115,952 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Manzo Pharmaceuticals, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Manzo Pharmaceuticals, Inc.. Coverage tracks Manzo Pharmaceuticals, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.